Hepatitis C Specialty Drugs

Hepatitis C specialty drugs play a central role in the management and elimination of hepatitis C across clinical, institutional, and public health treatment programs.

These therapies are primarily based on anti hepatitis C drugs, designed to suppress viral replication and support long-term treatment outcomes under established medical guidelines.

Oddway International operates as an international supplier of hepatitis C drugs, supporting licensed distributors, hospitals, NGOs, and institutional buyers through regulated pharmaceutical supply channels.

Our activities focus on compliant sourcing, export coordination, and program-based supply.

Anti HCV drugs sourced from India

Anti hepatitis C medicines are commonly utilized in national treatment programs and specialty care settings where consistent access to quality-assured medicines is essential.

These hepatitis C specialty drugs are typically procured in bulk or through structured patient access pathways, aligned with destination-country regulatory requirements.

In global markets, many organizations rely on anti HCV drugs sourced from India due to established manufacturing standards and international supply capabilities.

Within this framework, hepatitis C medication are distributed through approved B2B and institutional procurement models.

International Sourcing & Treatment Programs

Antiviral therapy for hepatitis C forms the backbone of global elimination strategies. As part of these initiatives, healthcare providers and treatment programs may require access to anti hepatitis medicines supplied through compliant export mechanisms.

Oddway International supports this need by facilitating the international supply of hepatitis C specialty drugs for: